NUEC yields 2000000.00% · JNJ yields 2.13%● Live data
📍 NUEC pulled ahead of the other in Year 1
Combined, NUEC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NUEC + JNJ for your $10,000?
NuEarth Corporation develops and markets organic and biodegradable products in the United States. The company develops clean and green soil and water conservation technologies. Its product line includes NuSoil-liquid and granular products to change eroded property to productive land; SaltBlocker, an organic matter that limits the availability of salt cations and anions to the liquid soil, and changes the osmotic pressure within the soil composite; NuWater, a NuSoil water gel additive that helps prevent dust storms; and AquaSolv-liquid and granular formulations that slow down the infiltration rate of water and enables lateral spread through the root zone. The company also provides DustBlocker and RoadBinder, anionic polyacrylamides that enable road managers at mine and building sites to manage the dust and compaction. In addition, it develops the CL-40 line of products, such as cleaners, compound strippers, and graffiti removers for various cleaning applications. The company was formerly known as Eco-Rx, Inc. and changed its name to NuEarth Corporation in July 2009. NuEarth Corporation was founded in 1995 and is based in Miramar Beach, Florida.
Full NUEC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.